Yahoo! Finance: VRUS NewsLatest Financial News for PHARMASSET INC.Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th (PR Newswire)- September 17, 2008 Pharmasset, Inc. management will present at the UBS Global Life Sciences Conference being held from September 22-25, 2008 at the Grand Hyatt Hotel in New York City.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080917/clw005.h... Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2- September 8, 2008 Pharmasset, Inc. announces the preliminary results of the fourth cohort of a 4-week Phase 1 proof-of-concept clinical trial evaluating R7128 1500mg twice daily in combination with the standard of care , Pegasys plus Copegus in 20 patients chronically infected with hepatitis C virus genotype 2 or 3 who had not achieved a Sustained Viral Response with prior SOC therapy.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080908/clm035.h... Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences (PR Newswire)- September 5, 2008 Pharmasset, Inc. management will present at the 3rd Annual Citi Biotech Day being held September 8, 2008, at the Citi Executive Conference Center, New York, NY.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080905/clf051.h... |